On January 19, 2021, the amendment of the German Act against Restraints of Competition ("ARC") has entered into force. In addition to the significant adjustments to the ARC regarding.
To embed, copy and paste the code into your website or blog:
Yesterday, the 10th amendment to the German Act against Restraints of Competition (Gesetz gegen Wettbewerbsbeschränkungen – GWB ) entered into force, and with it the most substantial overhaul of German competition law in a long time. The new law contains a number of significant adjustments of the draft that was initially put to vote. This alert provides a quick overview of the new law’s most far-reaching features.
A. Companies with paramount cross-market significance
A novel regulatory approach targets a limited number of large gatekeepers and intermediaries in digital markets (new Section 19a GWB):
Friday, January 22, 2021
What Has Changed
On January 19, 2021, new German antitrust rules entered into force under the 10th amendment Act to the Act against Restraints of Competition (ARC) and introduced a number of significant changes.
The Act,
inter alia, revised the provisions relating to fine calculation for antitrust violations, and in doing so underlined the importance of compliance programs. For further changes, please refer to our previous blogpost.
Specifically, an objectively effective compliance program can now lead to a reduced fine being calculated if the German Federal Cartel Office (
FCO) concludes that certain conduct is in violation of antitrust rules, but the company had implemented appropriate compliance measures
DGAP-News: Medios AG / Key word(s): Takeover/Expansion
21.01.2021 / 16:20
Press Release
Medios AG: Successful completion of the Cranach Pharma acquisition - Market position strengthened significantly
Berlin, 21 January 2021 - Today, Medios successfully completed the takeover of the specialized pharmaceutical wholesaler Cranach Pharma GmbH, Hamburg. With the entry of the capital increase in kind in the commercial register, all closing conditions have now been fulfilled, meaning that the acquisition is completed. The German Federal Cartel Office had already granted clearance on 21 December 2020. As a result, Medios is now the largest provider of Specialty Pharma solutions in Germany.
Through the merger with Cranach Pharma GmbH, Medios partner network has grown from around 330 to around 500 specialized pharmacies. For the 2021 financial year, Medios expects, including the acquired Cranach Pharma GmbH, a significant increase in group sales to more than €1 billion.
Deutsches Kartellamt rechnet wegen Corona heuer mit Fusionswelle kurier.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kurier.at Daily Mail and Mail on Sunday newspapers.